StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
7819.T$843.00-0.71%
Fair $843.00+0.0%

7819.T

SHOBIDO Corporation

Consumer Defensive / Household & Personal ProductsTokyo

$843.00

-6.00 (-0.71%)

Fairly Valued+0.0%Fair Value $843.00Fund rank 30/100 · Data gapFallback financials|
SA 57/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 32% · confianza 25%

FCF escenarios

weak_data · normalized FCF $621.5M · quality 55.7/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 41/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

57/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 7819.TLocal privado en este navegador · SHOBIDO Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$10.7B

P/E

9.3x

↓

EV/EBITDA

6.2x

↓

ROE

13.2%

↑

Gross Margin

31.9%

↑

Debt/Equity

0.68

↑
52-Week Range$843
$588$1338

TradingView lightweight chart

7819.T price, volumen y niveles de valoración

Último $843.00Periodo +35.3%
Fair value: $843.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+8.6%

FCF CAGR

+53.2%

FCF margin

3.3%

FCF / Net income

0.75x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $22.12B · net income $977.9M · FCF $736.7M

2022-FY → 2025-FY

Gross margin

31.9%+4.1% pts

Operating margin

6.6%+3.0% pts

Net margin

4.4%+1.5% pts

FCF margin

3.3%+2.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$22.12B$22.12B$20.92B$20.44B$17.28B
Net Income$977.9M$977.9M$774.0M$475.4M$511.9M
EBITDA$1.83B$1.83B$1.33B$1.11B$1.04B
EPS——58.5935.9938.75
Gross Margin31.9%31.9%26.3%26.3%27.8%
Operating Margin6.6%6.6%4.8%4.3%3.7%
Net Margin4.4%4.4%3.7%2.3%3.0%
Balance Sheet
Debt/Equity0.680.680.720.840.88
Current Ratio2.142.14———
Cash Flow
Free Cash Flow$736.7M$736.7M$621.5M$-47.5M$204.9M
Returns
ROE13.2%13.2%11.8%7.7%8.7%
Valuation
P/E9.329.328.9913.5010.22
EV/EBITDA6.256.255.785.754.70
P/B1.501.501.061.030.89
Growth & Yield
Revenue Growth5.7%5.7%2.3%18.3%—
EPS Growth——62.8%-7.1%—
Dividend Yield3.9%3.9%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +46.5%

Total return

+46.5%

Start / end P/E

n/dx → n/dx

EPS bridge

58.59 → n/d

Residual

+42.6%

EPS growthn/d
Multiple reratingn/d
Dividend+3.9%
Residual / FX / buybacks / cross-term+42.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.